Open AccessHIV in pregnancy: Identification of intrapartum and perinatal HIV exposures
Author(s) -
Dorothy Moore,
Upton Allen
Publication year - 2019
Publication title -
paediatrics and child health
Language(s) - English
Resource type - Journals
eISSN - 1918-1485
pISSN - 1205-7088
DOI - 10.1093/pch/pxy181
Subject(s) - medicine , human immunodeficiency virus (hiv) , pregnancy , antiretroviral therapy , intensive care medicine , obstetrics , transmission (telecommunications) , prenatal care , pediatrics , viral load , immunology , environmental health , population , genetics , biology , electrical engineering , engineering
The benefits of human immunodeficiency virus (HIV) testing in pregnancy, when combined with appropriate maternal antiretroviral therapy and intrapartum and postnatal prophylaxis, are well established. The vertical rate of transmission of HIV in North America is now well below 2%. Efforts must continue to ensure that these benefits are sustained. Women who have received little or no prenatal care and those who present for delivery with unknown HIV status need immediate testing. As more infants are exposed to antiretroviral agents, strategies need to be implemented to ensure adequate follow-up of these infants. Issues relating to the identification of HIV-exposed infants are highlighted.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom